Abstract
The expression of 4-1BB has been known to be dependent on T cell activation. Recent studies have, however, revealed that 4-1BB expression is not restricted to T cells. We sought to determine the molecular basis for the differential gene expression. Here we report the expression pattern of two mouse 4-1BB transcripts, type I and type II. Whereas the type I transcript was specifically expressed on immune organ as previously reported, the type II transcript was ubiquitously expressed in tissues and various cell lines. However, both type I and type II transcript were highly induced on activated T cells. Primer extension assay of the two 4-1BB transcripts suggested that mouse 4-1BB had more than two transcripts. Using luciferase assay we have identified three promoter regions (PI, PII and PIII), which located on upstream region of second exon 1, first exon 1, and exon 2, respectively. In particular, the type I transcript was preferentially induced when naïve T cells are stimulated by anti-CD3 monoclonal antibody (mAb) since NF-κB specifically binds to the putative NF-κB element of PI. We have also shown that a splice variant, in which the transmembrane domain was deleted, could inhibit 4-1BB signaling. The splicing variant was highly induced by TCR stimulation. Our results reveal 4-1BB also has a negative regulation system through soluble 4-1BB produced from a splice variant induced under activation conditions.
Similar content being viewed by others
References
Alderson, M.R., Smith, C.A., Tough, T.W., Davis-Smith, T., Armitage, R.J., Falk, B., Roux, E., Baker, E., Sutherland, G.R., and Din, W.S. (1994). Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24, 2219–2227.
Boussaud, V., Soler, P., Moreau, J., Goodwin, R.G., and Hance, A.J. (1998). Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung. Eur. Respir. J. 12, 926–931.
Broll, K., Richter, G., Pauly, S., Hofstaedter, F., and Schwarz, H. (2001). CD137 expression in tumor vessel walls. High correlation with malignant tumors. Am. J. Clin. Pathol. 115, 543–549.
Cascino, I., Fiucci, G., Papoff, G., and Ruberti, G. (1995). Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154, 2706–2713.
Cascino, I., Papoff, G., De Maria, R., Testi, R., and Ruberti, G. (1996). Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 156, 13–17.
Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J., and Mountz, J.D. (1994). Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759–1762.
Christophi, G.P., Isackson, P.J., Blaber, S., Blaber, M., Rodriguez, M., and Scarisbrick, I.A. (2004). Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J. Neurochem. 91, 1439–1449.
DeBenedette, M.A., Chu, N.R., Pollok, K.E., Hurtado, J., Wade, W.F., Kwon, B.S., and Watts, T.H. (1995). Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J. Exp. Med. 181, 985–992.
DeBenedette, M.A., Shahinian, A., Mak, T.W., and Watts, T.H. (1997). Costimulation of CD28-T lymphocytes by 4-1BB ligand. J. Immunol. 158, 551–559.
Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475–1489.
Furtner, M., Straub, R.H., Kruger, S., and Schwarz, H. (2005). Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia. Leukemia 19, 883–885.
Futagawa, T., Akiba, H., Kodama, T., Takeda, K., Hosoda, Y., Yagita, H., and Okumura, K. (2002). Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14, 275–286.
Garni-Wagner, B.A., Lee, Z.H., Kim, Y.J., Wilde, C., Kang, C.Y., and Kwon, B.S. (1996). 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans. Cell. Immunol. 169, 91–98.
Goodwin, R.G., Din, W.S., Davis-Smith, T., Anderson, D.M., Gimpel, S.D., Sato, T.A., Maliszewski, C.R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., et al. (1993). Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23, 2631–2641.
Hai, M., Bidichandani, S.I., and Patel, P.I. (2001). Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene. J. Neurosci. Res. 65, 508–519.
Heinisch, I.V., Daigle, I., Knopfli, B., and Simon, H.U. (2000). CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Eur. J. Immunol. 30, 3441–3446.
Heinisch, I.V., Bizer, C., Volgger, W., and Simon, H.U. (2001). Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders. J. Allergy Clin. Immunol. 108, 21–28.
Hurtado, J.C., Kim, S.H., Pollok, K.E., Lee, Z.H., and Kwon, B.S. (1995). Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J. Immunol. 155, 3360–3367.
Hurtado, J.C., Kim, Y.J., and Kwon, B.S. (1997). Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158, 2600–2609.
Jian, J.L., Zhu, C.S., Xu, Z.W., Ouyang, W.M., Ma, D.C., Zhang, Y., Chen, L.J., Yang, A.G., and Jin, B.Q. (2006). Identification and characterization of the CD226 gene promoter. J. Biol. Chem. 281, 28731–28736.
Jung, H.W., Choi, S.W., Choi, J.I., and Kwon, B.S. (2004). Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis. Exp. Mol. Med. 36, 13–22.
Kim, K.M., Kim, H.W., Kim, J.O., Baek, K.M., Kim, J.G., and Kang, C.Y. (2002). Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes. Immunology 107, 472–479.
Kim, J.O., Kim, H.W., Baek, K.M., and Kang, C.Y. (2003). NF-kappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells. FEBS Lett. 541, 163–170.
Kohno, T., Brewer, M.T., Baker, S.L., Schwartz, P.E., King, M.W., Hale, K.K., Squires, C.H., Thompson, R.C., and Vannice, J.L. (1990). A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87, 8331–8335.
Kwon, B.S., and Weissman, S.M. (1989). cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86, 1963–1967.
Kwon, B.S., Kim, G.S., Prystowsky, M.B., Lancki, D.W., Sabath, D.E., Pan, J.L., and Weissman, S.M. (1987). Isolation and initial characterization of multiple species of T-lymphocyte subset cDNA clones. Proc. Natl. Acad. Sci. USA 84, 2896–2900.
Kwon, B.S., Kestler, D.P., Eshhar, Z., Oh, K.O., and Wakulchik, M. (1989). Expression characteristics of two potential T cell mediator genes. Cell. Immunol. 121, 414–422.
Kwon, B.S., Kozak, C.A., Kim, K.K., and Pickard, R.T. (1994). Genomic organization and chromosomal localization of the T-cell antigen 4-1BB. J. Immunol. 152, 2256–2262.
Kwon, B., Moon, C.H., Kang, S., Seo, S.K., and Kwon, B.S. (2000). 4-1BB: still in the midst of darkness. Mol. Cells 10, 119–126.
Langstein, J., and Schwarz, H. (1999). Identification of CD137 as a potent monocyte survival factor. J. Leukoc. Biol. 65, 829–833.
Langstein, J., Michel, J., Fritsche, J., Kreutz, M., Andreesen, R., and Schwarz, H. (1998). CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160, 2488–2494.
Langstein, J., Michel, J., and Schwarz, H. (1999). CD137 induces proliferation and endomitosis in monocytes. Blood 94, 3161–3168.
Lee, S.C., Ju, S.A., Pack, H.N., Heo, S.K., Suh, J.H., Park, S.M., Choi, B.K., Kwon, B.S., and Kim, B.S. (2005). 4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection. Infect. Immun. 73, 5144–5151.
Lotz, M., Setareh, M., von Kempis, J., and Schwarz, H. (1996). The nerve growth factor/tumor necrosis factor receptor family. J. Leukoc. Biol. 60, 1–7.
McHugh, R.S., Whitters, M.J., Piccirillo, C.A., Young, D.A., Shevach, E.M., Collins, M., and Byrne, M.C. (2002). CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311–323.
Michel, J., Langstein, J., Hofstadter, F., and Schwarz, H. (1998). A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur. J. Immunol. 28, 290–295.
Nocentini, G., Ronchetti, S., Bartoli, A., Spinicelli, S., Delfino, D., Brunetti, L., Migliorati, G., and Riccardi, C. (2000). Identification of three novel mRNA splice variants of GITR. Cell Death Differ. 7, 408–410.
Pizzolo, G., Vinante, F., Chilosi, M., Dallenbach, F., Josimovic-Alasevic, O., Diamantstein, T., and Stein, H. (1990). Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin’s disease: relationship with disease activity and clinical stage. Br. J. Haematol. 75, 282–284.
Pollok, K.E., Kim, Y.J., Zhou, Z., Hurtado, J., Kim, K.K., Pickard, R.T., and Kwon, B.S. (1993). Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150, 771–781.
Pollok, K.E., Kim, Y.J., Hurtado, J., Zhou, Z., Kim, K.K., and Kwon, B.S. (1994). 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur. J. Immunol. 24, 367–374.
Pollok, K.E., Kim, S.H., and Kwon, B.S. (1995). Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4. Eur. J. Immunol. 25, 488–494.
Reali, C., Curto, M., Sogos, V., Scintu, F., Pauly, S., Schwarz, H., and Gremo, F. (2003). Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2. J. Neurosci. Res. 74, 67–73.
Reynolds, P.J., Lesley, J., Trotter, J., Schulte, R., Hyman, R., and Sefton, B.M. (1990). Changes in the relative abundance of type I and type II lck mRNA transcripts suggest differential promoter usage during T-cell development. Mol. Cell. Biol. 10, 4266–4270.
Saoulli, K., Lee, S.Y., Cannons, J.L., Yeh, W.C., Santana, A., Goldstein, M.D., Bangia, N., DeBenedette, M.A., Mak, T.W., Choi, Y., et al. (1998). CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187, 1849–1862.
Schwarz, H., Valbracht, J., Tuckwell, J., von Kempis, J., and Lotz, M. (1995). ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85, 1043–1052.
Schwarz, H., Blanco, F.J., von Kempis, J., Valbracht, J., and Lotz, M. (1996). ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 87, 2839–2845.
Seko, Y., Sugishita, K., Sato, O., Takagi, A., Tada, Y., Matsuo, H., Yagita, H., Okumura, K., and Nagai, R. (2004). Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu’s arteritis. J. Vasc. Res. 41, 84–90.
Setareh, M., Schwarz, H., and Lotz, M. (1995). A mRNA variant encoding a soluble form of 4-1BB, a member of the murine NGF/TNF receptor family. Gene 164, 311–315.
Shuford, W.W., Klussman, K., Tritchler, D.D., Loo, D.T., Chalupny, J., Siadak, A.W., Brown, T.J., Emswiler, J., Raecho, H., Larsen, C.P., et al. (1997). 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186, 47–55.
Takahashi, C., Mittler, R.S., and Vella, A.T. (1999). Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162, 5037–5040.
Tao, L., Dong, Z., Zannis-Hadjopoulos, M., and Price, G.B. (2001). Immortalization of human WI38 cells is associated with differential activation of the c-myc origins. J. Cell. Biochem. 82, 522–534.
Watts, T.H. (2005). TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23–68.
Wilcox, R.A., Chapoval, A.I., Gorski, K.S., Otsuji, M., Shin, T., Flies, D.B., Tamada, K., Mittler, R.S., Tsuchiya, H., Pardoll, D.M., et al. (2002). Cutting edge: Expression of functional CD137 receptor by dendritic cells. J. Immunol. 168, 4262–4267.
Xiao, Z.S., Simpson, L.G., and Quarles, L.D. (2003). IRES-dependent translational control of Cbfa1/Runx2 expression. J. Cell. Biochem. 88, 493–505.
Yamada, A., Takaki, S., Hayashi, F., Georgopoulos, K., Perlmutter, R.M., and Takatsu, K. (2001). Identification and characterization of a transcriptional regulator for the lck proximal promoter. J. Biol. Chem. 276, 18082–18089.
Zupan, A.A., Osborne, P.A., Smith, C.E., Siegel, N.R., Leimgruber, R.M., and Johnson, E.M., Jr. (1989). Identification, purification, and characterization of truncated forms of the human nerve growth factor receptor. J. Biol. Chem. 264, 11714–11720.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kim, J.D., Kim, C.H. & Kwon, B.S. Regulation of mouse 4-1BB expression: Multiple promoter usages and a splice variant. Mol Cells 31, 141–149 (2011). https://doi.org/10.1007/s10059-011-0018-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-011-0018-6